Qiming Venture Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).
HardwareHealthtechMedical DevicesMinneapolis, US
Martin Mayse(Co-founder)Steve Dimmer(Co-founder)Dennis Wahr(President & CEO)Lisa Flaherty(Chief Strategy Officer)Steve Sathre(Vice President of Finance)Steve Paidosh(Vice President of Operations)
Board seatGary Rieschel· per SEC Form D · $68.2M raise · filed Jan 2022
Co-investorsWindham Capital PartnersLightstone Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.